Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125562641 | 12556264 | 1 | I | 20160628 | 20160707 | 20160714 | 20160714 | EXP | US-AMGEN-USASL2016089034 | AMGEN | 60.00 | YR | A | M | Y | 0.00000 | 20160714 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125562641 | 12556264 | 1 | PS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Unknown | 30 MG, QD | 21688 | 30 | MG | TABLET | QD | ||||||
| 125562641 | 12556264 | 2 | SS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | 21688 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125562641 | 12556264 | 1 | Blood parathyroid hormone increased |
| 125562641 | 12556264 | 2 | Blood phosphorus increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125562641 | 12556264 | DE |
| 125562641 | 12556264 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125562641 | 12556264 | Blindness | |
| 125562641 | 12556264 | Deafness | |
| 125562641 | 12556264 | Death | |
| 125562641 | 12556264 | Leg amputation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |